CXCL13 and melanoma: A 12-chemokine gene expression signature including CCL2-5, CCL8, CCL18, CCL19, CCL21, CXCL9-11, and CXCL13 has been previously reported to serve as a predictor for the presence of TLS in melanoma specimens in association with improved OS (7).